Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts.
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive disorder characterized by macrocephaly, deterioration of motor functions with ataxia, and spasticity, eventuating in mental decline. The brain appears swollen on magnetic resonance imaging, with diffuse white-matter abnormalities and the invariable presence of subcortical cysts. MLC was recently localized on chromosome 22q(tel). We have narrowed down the critical region by linkage analysis of 11 informative families with MLC to a region of approximately 250 kb, containing four known genes. One family with two patients who were siblings did not display linkage between the MLC phenotype and any of the analyzed microsatellite markers on chromosome 22q(tel), suggesting genetic heterogeneity and the existence of at least a second MLC locus. The maximum two-point LOD score for the 11 families was 6.6 at recombination fraction .02. Twelve different mutations in seven informative and six uninformative families were found in one of the candidate genes, KIAA0027, which we renamed "MLC1." The gene encodes a putative membrane protein with eight predicted transmembrane domains. The patients of one family were compound heterozygotes for mutations that both introduced stop codons. The mutations further included frameshifts, splice-acceptor mutations, a putative splice-donor mutation, and amino acid substitutions of residues in predicted transmembrane domains. These data provide strong evidence that mutations of MLC1 cause the disease.
Leegwater
P A
PA
Department of Clinical Chemistry, Free University Medical Center, 1007 MB Amsterdam, The Netherlands. leegwater@azvu.nl
Yuan
B Q
BQ
van der Steen
J
J
Mulders
J
J
Könst
A A
AA
Boor
P K
PK
Mejaski-Bosnjak
V
V
van der Maarel
S M
SM
Frants
R R
RR
Oudejans
C B
CB
Schutgens
R B
RB
Pronk
J C
JC
van der Knaap
M S
MS
D000483:Alleles; D000595:Amino Acid Sequence; D001259:Ataxia / Q000150:complications / Q000235:genetics; D001483:Base Sequence; D001921:Brain / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000150:complications / Q000235:genetics*; D002874:Chromosome Mapping; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D019465:Craniofacial Abnormalities / Q000150:complications / Q000235:genetics*; D003560:Cysts / Q000150:complications / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D018740:Genetic Heterogeneity; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008126:Lod Score; D008297:Male; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics*; D018895:Microsatellite Repeats / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D017434:Protein Structure, Tertiary; D016415:Sequence Alignment
C425069:MLC1 protein, human; D008565:Membrane Proteins